Although these effects have not been validated through large-scale clinical trials, their potential in the field of skin beauty cannot be ignored based on the pharmacological mechanism of PT-141
Headache is reported by approximately 1015% of patients and usually resolves within the first month of therapy
Dickerson F, Adamos M, Katsafanas E, Khushalani S, Origoni A, Savage C, et al
Research findings are available online in the journal Science Advances
This is really one of the remarkable findings. Among specific GLP-1s, the strongest reduction in risk for AF occurred with semaglutide (Ozempic/Wegovy, Novo Nordisk
For subsequent refills or if you were previously on the medication, follow-ups are required every 6 months